Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease

Clinical and Experimental Immunology

Volumn 177, Issue 3, 2014, Pages 611-617

  Tosco, A ^a   Auricchio, R ^a   Aitoro, R ^a   Ponticelli, D ^a   Primario, M ^a   Miele, E ^a   Rotondi Aufiero, V ^b   Discepolo, V ^a   Greco, L ^a   Troncone, R ^a   Maglio, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Institute of Food Sciences Immunobiology   (Italy)

Author keywords

Anti tissue transglutaminase 2; Coeliac disease; Gluten free diet; Intestinal antibodies

Indexed keywords

GLIADIN; GLIADIN PEPTIC TRYPTIC DIGEST; GLIADIN PEPTIDE[31-43]; IMMUNOGLOBULIN A ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CHILD; CULTURE MEDIUM; DISEASE DURATION; DUODENUM BIOPSY; DUODENUM MUCOSA; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; INTESTINE INJURY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TISSUE CULTURE; TISSUE INJURY;

ANTI-TISSUE TRANSGLUTAMINASE 2; COELIAC DISEASE; GLUTEN-FREE DIET; INTESTINAL ANTIBODIES;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET, GLUTEN-FREE; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; MIDDLE AGED; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84904719160     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12366     Document Type: Article

References (32)

1. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2:647-655.
2. Dieterich W, Ehnis T, Bauer M etal. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797-801.
3. Bazzigaluppi E, Parma B, Tronconi GM etal. IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with ELISA assay in predicting severe intestinal damage. Ital J Pediatr 2010; 36:25.
4. Alessio MG, Tonutti E, Brusca I etal. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr 2012; 55:44-49.
5. Husby S, Koletzko S, Korponay-Szabó IR etal. for the ESPGHAN Working Group on Coeliac Disease Diagnosis, on behalf of the ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136-160.
6. Hogen Esch CE, Wolters VM, Gerritsen SA etal. Specific celiac disease antibodies in children on a gluten-free diet. Pediatrics 2011; 128:547-552.
7. Korponay-Szabo IR, Halttunen T, Szalai Z etal. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53:641-648.
8. Picarelli A, Sabbatella L, Di Tola M etal. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production. Am J Gastroenterol 2002; 97:95-98.
9. Mawhinney H, Love AH. Anti-reticulin antibody in jejunal juice in coeliac disease. Clin Exp Immunol 1975; 21:394-398.
10. Picarelli A, Di Tola M, Sabbatella L etal. Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. Scand J Gastroenterol 2006; 41:186-190.
11. Carroccio A, Di Prima L, Pirrone G etal. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem 2006; 52:1175-1180.
12. Picarelli A, Libanori V, De Nitto D etal. Organ culture system as a means to detect celiac disease. Ann Clin Lab Sci 2010; 40:85-87.
13. Di Niro R, Mesin L, Zheng NY etal. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med 2012; 18:441-445.
14. Marzari R, Sblattero D, Florian F etal. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001; 166:4170-4176.
15. Kappler M, Krauss-Etschmann S, Diehl V etal. Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study. BMJ 2006; 332:213-214.
16. Tosco A, Aitoro R, Auricchio A etal. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease. Clin Exp Immunol 2013; 171:69-75.
17. Picarelli A, Di Tola M, Marino M etal. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease. Transl Res 2013; 161:172-180.
18. Picarelli A, Maiuri L, Frate A etal. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 1996; 348:1065-1067.
19. Stenman SM, Lindfors K, Korponay-Szabo IR etal. Secretion of celiac disease antibodies after in vitro gladin challenge is dependent on small-bowel mucosal transglutaminase2-specific IgA deposits. BMC Immunol 2008; 9:6.
20. Tursi A, Brandimarte G, Giorgetti GM. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol 2003; 37:387-391.
21. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11:1185-1194.
22. Kurppa K, Collin P, Viljamaa M etal. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009; 136:816-823.
23. Mazzarella G, Maglio M, Paparo F etal. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003; 52:57-62.
24. Tosco A, Maglio M, Paparo F etal. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr 2008; 47:293-298.
25. Paparo F, Petrone E, Tosco A etal. Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol 2005; 100:2294-2298.
26. Donaldson MR, Book LS, Leiferman KM etal. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 2008; 42:256-260.
27. Kalhan S, Joseph P, Sharma S etal. Comparative study of histopathological Marsh grading with clinical and serological parameters in celiac iceberg of north India. Indian J Pathol Microbiol 2011; 54:279-283.
28. Maiuri L, Picarelli A, Boirivant M etal. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996; 110:1368-1378.
29. Tommasini A, Not T, Kiren V etal. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 2004; 89:512-515.
30. Vahedi K, Mascart F, Mary JY etal. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003; 98:1079-1087.
31. Fabiani E, Catassi C; International Working Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol 2001; 13:659-665.
32. Mesin L, Sollid LM, Di Niro R. The intestinal B-cell response in celiac disease. Front Immunol 2012; 3:313.